Clinical Trials Directory

Trials / Completed

CompletedNCT02274064

Motivating Type O- Blood Donors to Return

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
598 (actual)
Sponsor
Ohio University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study develops a motivational interview and implementation intention intervention for blood donor retention and tests the efficacy of this new approach among first-time, Group O donors.

Detailed description

In this study the investigators will recruit first-time Group O- and O+ donors four weeks after their donation using the donor databases of New York Blood Center and Hoxworth Blood Center. Eligible donors will be contacted via email and invited to participate in the study. Interested donors will be randomly assigned to either the Intervention condition where they will receive a motivational interview and implementation intention intervention phone call or to the Control condition where they will receive a standard donor recruitment phone call. Outcome measures will be assessed before and after the telephone contact using online questionnaires, and donation attempts will be tracked for one year. The investigators will use survival analysis to examine the effects of this intervention on retention during this one-year follow-up. Path analyses will also be used to examine potential mediators of the intervention effect. The investigators hypothesis is that donors who receive the motivational interview and implementation intention intervention will have larger increases in positive donation attitudes and perceived behavioral control which will contribute to enhanced intention and donation attempts.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMotivational Interview and Implementation IntentionTelephone call that includes motivational interviewing techniques and develops an implementation intention plan.

Timeline

Start date
2014-11-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2014-10-24
Last updated
2016-09-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02274064. Inclusion in this directory is not an endorsement.